Evidence map›Paper›PMID 34358181›Full record

ArticleVaccines2021

Willingness to Receive the COVID-19 and Seasonal Influenza Vaccines among the Saudi Population and Vaccine Uptake during the Initial Stage of the National Vaccination Campaign: A Cross-Sectional Survey.

Amel Ahmed Fayed, Abeer Salem Al Shahrani, Leenah Tawfiq Almanea, Nardeen Ibrahim Alsweed, Layla Mohammed Almarzoug, Reham Ibrahim Almuwallad, Waad Fahad Almugren

Abstract read
In one paragraph

Article in Vaccines, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Low uptake of seasonal influenza vaccination in Al-Jouf region of Saudi Arabia.Saudi pharmaceutical journal : SPJ : the official publication of the Saudi Pharmaceutical Society · 2023
    Article
  13. Review
  14. Article
  15. Review
  16. Article
  17. Article
  18. Review
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Amel Ahmed FayedDepartment of Clinical Sciences, College of Medicine, Princess Nourah bint Abdulrahman University, Riyadh 13412, Saudi Arabia.
Abeer Salem Al ShahraniDepartment of Clinical Sciences, College of Medicine, Princess Nourah bint Abdulrahman University, Riyadh 13412, Saudi Arabia.
Leenah Tawfiq AlmaneaDepartment of Clinical Sciences, College of Medicine, Princess Nourah bint Abdulrahman University, Riyadh 13412, Saudi Arabia.
Nardeen Ibrahim AlsweedDepartment of Clinical Sciences, College of Medicine, Princess Nourah bint Abdulrahman University, Riyadh 13412, Saudi Arabia.
Layla Mohammed AlmarzougDepartment of Clinical Sciences, College of Medicine, Princess Nourah bint Abdulrahman University, Riyadh 13412, Saudi Arabia.
Reham Ibrahim AlmuwalladDepartment of Clinical Sciences, College of Medicine, Princess Nourah bint Abdulrahman University, Riyadh 13412, Saudi Arabia.
Waad Fahad AlmugrenDepartment of Clinical Sciences, College of Medicine, Princess Nourah bint Abdulrahman University, Riyadh 13412, Saudi Arabia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This study aimed to assess the willingness to receive the coronavirus disease 2019 (COVID-19) and seasonal influenza vaccines and vaccine uptake during the early stage of the national vaccination campaign in Saudi Arabia. A cross-sectional online survey was conducted among adult Saudis between 20 January and 20 March 2021. The questionnaire addressed vaccine hesitancy, perceived risk, willingness, and vaccine uptake. Approximately 39% of the participants expressed vaccine hesitancy, and 29.8% and 24% felt highly vulnerable to contracting COVID-19 and seasonal influenza, respectively. The majority (59.5%) were willing to receive the COVID-19 vaccine, although only 31.7% were willing to receive the flu vaccine. Adjusted analysis showed that vaccine hesitancy (OR 0.34, 95% CI 0.27-0.43) and the perception of being at high risk (OR 2.78, 95% CI 1.68-4.60) independently affected the intention to be vaccinated. Vaccine hesitancy was similar among those who were willing to be vaccinated (29.8%) and those who had already been vaccinated (33.1%). The perceived risk was significantly higher among those who had been vaccinated (48.1%) than among those who were willing to be vaccinated but had not yet been vaccinated (29.1%). In conclusion, the acceptance of the COVID-19 vaccine in Saudi Arabia is high. Saudis who received the vaccine had a similar level of vaccine hesitancy and a higher level of perceived risk.

Indexed as

COVID-19pandemicSaudi Arabiaseasonal influenzauptakevaccine

Identifiers

PMID34358181
PMCPMC8310157

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.